Antibiotic Therapy and Treatment Failure in Patients Hospitalized for Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Authors:
  • PPPenelope S. Pekow
    Penelope S. Pekow
  • MLMaureen Lahti
    Maureen Lahti
  • OBOren Brody
    Oren Brody
  • DSDaniel J. Skiest
    Daniel J. Skiest
  • PLPeter K. Lindenauer
    Peter K. Lindenauer

Abstract
Chronic obstructive pulmonary disease (COPD) affects at least 12 million US residents and is the fourth leading cause of death in the United States.1 Acute exacerbations of COPD are responsible for more than 600 000 hospitalizations annually, resulting in direct costs of more than $20 billion.2 Respiratory infections appear to be the most frequent cause of COPD exacerbation, accounting for 50% to 80% of all exacerbations.3-5 Although as many as two-thirds of these may be viral infections, COPD treatment guidelines nevertheless recommend antibiotic treatment for patients with purulent sputum and either an increase in sputum production or an increase in dyspnea.2,6-9 The evidence supporting these recommendations comes from 11 small randomized trials demonstrating that antibiotics can reduce short-term mortality and treatment failure.10 Patients with more severe disease, especially those receiving mechanical ventilation, appear to benefit the most.11